This conclusion is further supported by the ability of Lpar5−/− mice and Lpar5−/− tumor-specific CD8 T cells to better control EG7 lymphoma and B16 melanoma growth, respectively, compared to wild type (Figures 4E,F). Here, CD8A is linked to melanoma.